Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
91.46 CHF | +1.02% | +4.26% | +8.07% |
05-06 | NOVARTIS AG : UBS maintains a Buy rating | ZD |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.07% | 204B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.43% | 239B | |
-8.02% | 198B | |
+8.62% | 168B | |
+4.60% | 125B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Barclays remains a Sell rating